Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 3Gliosarcoma 3Glioma 3Glioblastoma 3Dendritic Cell Sarcoma, Interdigitating 3Oligodendroglioma 2Astrocytoma 2Sarcoma, Kaposi 1Recurrence 1Neuroectodermal Tumors, Primitive 1Meningioma 1Lymphoma 1Histiocytosis, Langerhans-Cell 1Histiocytic Sarcoma 1Heart Failure 1HIV Infections 1Erdheim-Chester Disease 1Ependymoma 1Central Nervous System Neoplasms 1Cardiotoxicity 1Brain Neoplasms 1AIDS-related Kaposi sarcoma 1

Interventions

Doxorubicin 4Dexrazoxane 3Methotrexate 2Cisplatin 2pegfilgrastim 1Vincristine 1Rituximab 1Razoxane 1Prednisolone 1Neoadjuvant Therapy 1Leucovorin 1Lenalidomide 1Ifosfamide 1Filgrastim 1Etoposide 1Cyclophosphamide 1Chemotherapy, Adjuvant 1Captopril 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cardiotoxicity × Lenalidomide × Sarcoma × Clear all
NCT06220032 2026-01-05

HO170DLBCL

Stichting Hemato-Oncologie voor Volwassenen Nederland

Phase 3 Recruiting
324 enrolled
LymphoidSarcoma

Heart Failure, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡